Youhai Jiang

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Targeting FGFR1-regulated SPP1 signaling repolarizes immunosuppressive macrophages and sensitizes Hepatocellular Carcinoma to anti-PD-1 therapy.

Targeting FGFR1-regulated SPP1 signaling repolarizes immunosuppressive macrophages and sensitizes Hepatocellular Carcinoma to anti-PD-1 therapy.

Journal: Cancer letters
Published: October 11, 2025

ADCY7 dictates N-cadherin stability to inhibit HCC metastasis.

ADCY7 dictates N-cadherin stability to inhibit HCC metastasis.

Journal: JHEP reports : innovation in hepatology
Published: June 06, 2025

Single-cell analysis reveals CD34+CD90+ endothelial cells promote tumor metastasis in gallbladder cancer.

Single-cell analysis reveals CD34+CD90+ endothelial cells promote tumor metastasis in gallbladder cancer.

Journal: NPJ precision oncology
Published: October 24, 2024

Deciphering cholangiocarcinoma heterogeneity and specific progenitor cell niche of extrahepatic cholangiocarcinoma at single-cell resolution.

Deciphering cholangiocarcinoma heterogeneity and specific progenitor cell niche of extrahepatic cholangiocarcinoma at single-cell resolution.

Journal: Journal of hematology & oncology
Published: October 07, 2024

Nuclear translocation of plasma membrane protein ADCY7 potentiates T cell-mediated antitumour immunity in HCC.

Nuclear translocation of plasma membrane protein ADCY7 potentiates T cell-mediated antitumour immunity in HCC.

Journal: Gut
Published: May 21, 2024

Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma.

Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma.

Journal: Cell discovery
Published: December 30, 2021

Patient-derived organoids for personalized gallbladder cancer modelling and drug screening.

Patient-derived organoids for personalized gallbladder cancer modelling and drug screening.

Journal: Clinical and translational medicine
Published: September 02, 2021

Progress and Challenges in Precise Treatment of Tumors With PD-1/PD-L1 Blockade.

Progress and Challenges in Precise Treatment of Tumors With PD-1/PD-L1 Blockade.

Journal: Frontiers in immunology
Published: October 25, 2019

ACADL plays a tumor-suppressor role by targeting Hippo/YAP signaling in hepatocellular carcinoma.

ACADL plays a tumor-suppressor role by targeting Hippo/YAP signaling in hepatocellular carcinoma.

Journal: NPJ precision oncology
Published: October 11, 2019
Showing 1-9 of 9

Last Updated: 09/26/2026